RE:RE:RE:RE:Zenith,,,,,Julie Cherrington was our CEO at Zenith Epigenetics at the time this patent issue came to the forefront. She didnt last much longer after that. It is very possible that she failed to protect the specific technology around the molecule. But it did seem less obvious at the time. So DM may not have had any involvement in the embarrassing circumstances of having to pull our trail off the schedule.